As already reported, Chapter <1> of the US American Pharmacopoeia has been revised again. Find out more about the chapter on Injections and Implanted Drug Products (Parenterals)-Product Quality Tests.
As already reported in the news “Second Revision of USP Chapter <1> Injections and Implanted Drug Products (Parenterals)-Product Quality Tests“, USP’s Chapter <1> “Injections and Implanted Drug Products (Parenterals)-Product Quality Tests’ has been revised again. New information is now available.
The USP published these details on 25 March. The revised version now contains a table of contents for a better overview whereas the Product Performance Test at the end of the Chapter has been deleted. All details about the new version of USP’s Chapter <1> can be found on the USP website.
The revised Chapter will become effective on May 1st, 2016.
//////////Revision, USP Chapter 1, US American Pharmacopoeia
DRUG REGULATORY AFFAIRS INTERNATIONAL 